Ivabradine is not effective in the treatment of premature heart beats, and the drug is not recommended for premature beats. It is recommended to consult a doctor in time, symptomatic targeted use of drugs.
Ivabradine is an antiarrhythmic drug that works by inhibiting the sinus node inward If current, and is mainly used in patients with sinus tachycardia who have poor therapeutic efficacy, cannot tolerate or are prohibited from using beta-blockers. There is no pharmacologic mechanism by which premature beats can be treated; therefore, ivabradine is not recommended for premature beats.
Premature beats can be categorized as atrial or ventricular. Atrial premature beats usually do not require treatment. When symptoms are significant or predispose to supraventricular tachycardia, beta-blockers, non-dihydropyridine calcium channel blockers, propafenone, amiodarone, and other medications may be used.
Ventricular tachycardia without organic heart disease and mild symptoms do not need treatment, but when the symptoms are obvious, the above drugs can also be used to alleviate the symptoms. When accompanied by organic heart disease, the treatment of the primary disease should be the main focus. Please follow the doctor’s instructions for the specific medication program.